Andrea Tan
Stock Analyst at Goldman Sachs
(0)
# 4415
Out of 5,320 analysts
50
Total ratings
38.71%
Success rate
-16.64%
Average return
Main Sectors:
Top Industries:
| Name | Action | Price Target | Current | % Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
IOVA Iovance Biotherapeut... | Maintains: Buy | 18 16 | 3.08 | 419.48% | 6 | Apr 17, 2025 | |
DAWN Day One Biopharmaceu... | Maintains: Buy | 39 27 | 7.14 | 278.15% | 6 | Mar 25, 2025 | |
TARS Tarsus Pharmaceutica... | Maintains: Neutral | 36 41 | 48.54 | -15.53% | 3 | Nov 15, 2024 | |
INSM Insmed | Maintains: Strong Buy | 74 102 | 69.49 | 46.78% | 9 | Jul 10, 2024 | |
SGMT Sagimet Biosciences | Maintains: Neutral | 23 6 | 2.4 | 150% | 5 | Jul 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 31 | 12.06 | 157.05% | 1 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Downgrades: Sell | 3 2 | 0.32 | 525% | 3 | Jun 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Reinstates: Sell | 2 | 3.21 | -37.69% | 1 | Dec 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Neutral | 17 | 31.23 | -45.57% | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Buy | 160 | 161.9 | -1.17% | 1 | Nov 20, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 27 24 | 2.46 | 875.61% | 2 | Aug 4, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Sell | 10 4 | 1.25 | 220% | 2 | Jan 9, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Buy | 178 375 | 295.51 | 26.9% | 1 | Dec 20, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Initiates Coverage On: Sell | 13 | 4.78 | 171.97% | 1 | Dec 15, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 2 2 | 0.06 | 2233.33% | 6 | Nov 7, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade
| Maintains: Neutral | 6 4 | 0.7 | 471.43% | 2 | May 24, 2022 |